Skip to main content
Clinical Trials/NCT01769144
NCT01769144UnknownNot Applicable

Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh---A Randomised Controlled Trial

Kaohsiung Veterans General Hospital.2 sites in 1 country70 target enrollmentStarted: January 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
70
Locations
2
Primary Endpoint
wound infection rate

Study Overview

Brief Summary

This study aims to compare the effectiveness of two wound dressings, Acticoat Absorbent (AA) and BCT Antimicrobial (BCT) on Split Thickness Skin Graft (STSG) donor site.

Detailed Description

Seventy patients who undergo STSG procedure in Kaohsiung Veterans General Hospital will be recruited. Two donor sites of equal lengths and widths on the same thigh, which are at least 2 cm apart will be covered randomly with AA and BCT each. Wound healing rate and infection rate will be assessed at 7 and 14 days after surgery. Degrees of pain and itchiness will be assessed daily with Visual Analogue Scale for the first 7 post-operative days. Scar appearance will be assessed with Vancouver Scar Scale 1, 3 and 6 months post-operatively.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients who need STSG, longer than 8 cm and wider than 5 cm, from their thighs

Exclusion Criteria

  • systemic steroid
  • old scar on thigh
  • systemic infection
  • anticipated use of antibiotics for more than 24 hours after operation
  • pregnancy
  • previous chemotherapy within 3 months before operation
  • anticipated chemotherapy within 3 months after operation
  • not over 20 years old
  • non-communicable
  • burn area more than 20% total body surface area
  • systemic auto-immune disease
  • liver cirrhosis
  • allergy to carbon fiber or alginate
  • anticipated MRI study
  • dry wound

Arms & Interventions

Acticoat Absorbent

Active Comparator

Acticoat Absorbent wound dressing

Intervention: Acticoat Absorbent (Device)

BCT wound dressing

Experimental

wound dressing

Intervention: BCT (Device)

Outcomes

Primary Outcomes

wound infection rate

Time Frame: 7 days

wound healing rate

Time Frame: 14 days

percentage of wound area that has healed at this time

Secondary Outcomes

  • scar appearance(6 months)
  • pain and itchiness(7 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kuei-Chang Hsu

Consultant Surgeon

Kaohsiung Veterans General Hospital.

Study Sites (2)

Loading locations...

Similar Trials